JP2015504909A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015504909A5 JP2015504909A5 JP2014553715A JP2014553715A JP2015504909A5 JP 2015504909 A5 JP2015504909 A5 JP 2015504909A5 JP 2014553715 A JP2014553715 A JP 2014553715A JP 2014553715 A JP2014553715 A JP 2014553715A JP 2015504909 A5 JP2015504909 A5 JP 2015504909A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- sulfane
- galactopyranosyl
- bis
- benzopyran
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12152413.6A EP2620443A1 (en) | 2012-01-25 | 2012-01-25 | Novel galactoside inhibitors of galectins |
| EP12152413.6 | 2012-01-25 | ||
| PCT/EP2013/051339 WO2013110704A1 (en) | 2012-01-25 | 2013-01-24 | Novel galactoside inhibitors of galectins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015504909A JP2015504909A (ja) | 2015-02-16 |
| JP2015504909A5 true JP2015504909A5 (enExample) | 2016-03-10 |
| JP6158840B2 JP6158840B2 (ja) | 2017-07-05 |
Family
ID=47598867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014553715A Expired - Fee Related JP6158840B2 (ja) | 2012-01-25 | 2013-01-24 | ガレクチンのガラクトシド阻害剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9353141B2 (enExample) |
| EP (2) | EP2620443A1 (enExample) |
| JP (1) | JP6158840B2 (enExample) |
| CN (1) | CN104066743B (enExample) |
| CA (1) | CA2854986C (enExample) |
| ES (1) | ES2559857T3 (enExample) |
| IN (1) | IN2014DN05772A (enExample) |
| WO (1) | WO2013110704A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE390140T1 (de) | 1999-11-03 | 2008-04-15 | Bristol Myers Squibb Co | Arzneimittel, umfassend eine kombination aus metformin und glibenclamide |
| US6586438B2 (en) | 1999-11-03 | 2003-07-01 | Bristol-Myers Squibb Co. | Antidiabetic formulation and method |
| US9243021B2 (en) | 2012-10-31 | 2016-01-26 | Galecto Biotech Ab | Galactoside inhibitor of galectins |
| CA2926480A1 (en) * | 2012-11-15 | 2014-05-22 | Tufts University | Methods, compositions and kits for treating, modulating, or preventing ocular angiogenesis or fibrosis in a subject using a galectin protein inhibitor |
| US9907814B2 (en) | 2012-12-20 | 2018-03-06 | Henry Ford Health System | Method for treating diastolic heart failure by inhibiting galectin-3 |
| US12390486B2 (en) | 2012-12-20 | 2025-08-19 | Henry Ford Health System | Method for treating diastolic heart failure by inhibiting galectin-3 |
| CA2949441A1 (en) * | 2014-07-09 | 2016-01-14 | Galecto Biotech Ab | Novel hybrid galactoside inhibitor of galectins |
| JP6904906B2 (ja) * | 2015-01-30 | 2021-07-21 | ガレクト・バイオテック・エイビイ | ガレクチンの新規なガラクトシド阻害剤 |
| CN109071585B (zh) * | 2016-03-04 | 2022-08-16 | 卡莱克汀科学有限责任公司 | 预防和治疗半乳糖凝集素相关疾病的硒代半乳糖苷化合物及其用途 |
| EP3484903A1 (en) * | 2016-07-12 | 2019-05-22 | Galecto Biotech AB | Alpha-d-galactoside inhibitors of galectins |
| CA3025867A1 (en) * | 2016-07-12 | 2018-01-18 | Galecto Biotech Ab | Alpha-d-galactoside inhibitors of galectins |
| CA3062648A1 (en) | 2017-05-12 | 2018-11-15 | Galectin Sciences, Llc | Compounds for the prevention and treatment of diseases and the use thereof |
| JP7304863B2 (ja) | 2017-12-29 | 2023-07-07 | グリコミメティクス， インコーポレイテッド | Ｅ－セレクチンおよびガレクチン－３のヘテロ二機能性阻害剤 |
| JP2021529163A (ja) | 2018-06-29 | 2021-10-28 | グリコス バイオメディカル オーワイ | コンジュゲート |
| AU2019416330A1 (en) | 2018-12-27 | 2021-07-01 | Glycomimetics, Inc. | Galectin-3 inhibiting c-glycosides |
| US11845771B2 (en) | 2018-12-27 | 2023-12-19 | Glycomimetics, Inc. | Heterobifunctional inhibitors of E-selectin and galectin-3 |
| JP7612663B2 (ja) * | 2019-08-09 | 2025-01-14 | イドルシア・ファーマシューティカルズ・リミテッド | （２－アセタミジル）チオ－ベータ－ｄ－ガラクトピラノシド誘導体 |
| US20230038373A1 (en) | 2019-12-18 | 2023-02-09 | Glykos Biomedical Oy | Stabile conjugate |
| CN116270672A (zh) * | 2023-02-27 | 2023-06-23 | 江苏科技大学 | β-D-硫代葡萄糖钠盐在制备缓解或治疗急性肾损伤的药物中的应用 |
| CZ2023132A3 (cs) | 2023-04-04 | 2024-10-16 | Ústav Chemických Procesů Av Čr, V. V. I. | Komplexy ruthenia pro inhibici galektinů, způsob jejich výroby a jejich použití |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0100172D0 (sv) | 2001-01-22 | 2001-01-22 | Ulf Nilsson | New inhibitors against galectins |
| SE0401301D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel 3-triazolyl-galactoside inhibitors of galectins |
| SE0401300D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel Galactoside Inhibitors of Galectins |
| CN103497228B (zh) | 2008-05-16 | 2016-08-10 | 格莱克特生物技术公司 | 半乳糖苷抑制剂的合成 |
| EP2424873B1 (en) | 2009-04-28 | 2017-11-15 | Galecto Biotech AB | Novel galactoside inhibitors of galectins |
| EP3278805A1 (en) | 2012-10-31 | 2018-02-07 | Galecto Biotech AB | Diagnosing pulmonary fibrosis |
-
2012
- 2012-01-25 EP EP12152413.6A patent/EP2620443A1/en not_active Withdrawn
-
2013
- 2013-01-24 CA CA2854986A patent/CA2854986C/en not_active Expired - Fee Related
- 2013-01-24 US US14/364,169 patent/US9353141B2/en not_active Expired - Fee Related
- 2013-01-24 IN IN5772DEN2014 patent/IN2014DN05772A/en unknown
- 2013-01-24 CN CN201380006432.7A patent/CN104066743B/zh not_active Expired - Fee Related
- 2013-01-24 EP EP13700935.3A patent/EP2807176B1/en not_active Not-in-force
- 2013-01-24 ES ES13700935.3T patent/ES2559857T3/es active Active
- 2013-01-24 WO PCT/EP2013/051339 patent/WO2013110704A1/en not_active Ceased
- 2013-01-24 JP JP2014553715A patent/JP6158840B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015504909A5 (enExample) | ||
| JP2014511891A5 (enExample) | ||
| JP2016518328A5 (enExample) | ||
| JP2018509409A5 (enExample) | ||
| JP2019524883A5 (enExample) | ||
| JP2019518766A5 (enExample) | ||
| JP2015508092A5 (enExample) | ||
| JP2020502047A5 (enExample) | ||
| JP2020510664A5 (enExample) | ||
| JP2017515901A5 (enExample) | ||
| SI2743266T1 (en) | Protein kinase inhibitors (variants), their use in the treatment of oncological diseases and the pharmaceutical composition on their basis | |
| JP2015528812A5 (enExample) | ||
| JP2016503797A5 (enExample) | ||
| CN106660974A (zh) | 含氨磺酰基的1,2,5‑噁二唑类衍生物、其制备方法及其在医药上的应用 | |
| JP2016505637A5 (enExample) | ||
| JP2016540749A5 (enExample) | ||
| JP2014521625A5 (enExample) | ||
| JP2013523846A5 (enExample) | ||
| JP2019518079A5 (enExample) | ||
| RU2016151420A (ru) | Новое терапевтическое применение производных бензилиденгуанидина для лечения протеинопатий | |
| JP2019535723A5 (enExample) | ||
| JP2015535257A5 (enExample) | ||
| JP2015131856A5 (enExample) | ||
| JP2016522254A5 (enExample) | ||
| JP2016532647A5 (enExample) |